Axsome Therapeutics Inc
NASDAQ:AXSM
Axsome Therapeutics Inc
NASDAQ:AXSM
Price:
98.06
USD
2.52%
Market Closed
Market Cap:
4.8B
USD
Balance Sheet
Balance Sheet Decomposition
Axsome Therapeutics Inc
Axsome Therapeutics Inc
| Current Assets | 485.1m |
| Cash & Short-Term Investments | 315.4m |
| Receivables | 142m |
| Other Current Assets | 27.7m |
| Non-Current Assets | 83.4m |
| PP&E | 6m |
| Intangibles | 58.9m |
| Other Non-Current Assets | 18.5m |
Balance Sheet
Axsome Therapeutics Inc
Axsome Therapeutics Inc
Currency: USD
Millions
Annual
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
3
|
48
|
37
|
34
|
14
|
220
|
184
|
87
|
201
|
386
|
|
| Cash |
0
|
0
|
0
|
0
|
14
|
220
|
184
|
87
|
0
|
0
|
|
| Cash Equivalents |
3
|
48
|
37
|
34
|
0
|
0
|
0
|
0
|
201
|
386
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
38
|
95
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
38
|
95
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
15
|
|
| Other Current Assets |
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
3
|
8
|
|
| Total Current Assets |
3
|
49
|
38
|
35
|
15
|
220
|
184
|
87
|
246
|
504
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
8
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
60
|
53
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
12
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
11
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
12
|
|
| Total Assets |
3
N/A
|
49
+1 654%
|
38
-22%
|
36
-7%
|
15
-57%
|
221
+1 332%
|
186
-16%
|
88
-53%
|
332
+278%
|
588
+77%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
2
|
4
|
3
|
4
|
11
|
14
|
13
|
39
|
41
|
|
| Accrued Liabilities |
0
|
1
|
3
|
3
|
4
|
11
|
10
|
10
|
52
|
92
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
6
|
6
|
|
| Total Current Liabilities |
1
|
3
|
7
|
12
|
11
|
25
|
23
|
23
|
97
|
139
|
|
| Long-Term Debt |
4
|
0
|
10
|
7
|
4
|
17
|
48
|
49
|
94
|
178
|
|
| Other Liabilities |
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
31
|
80
|
|
| Total Liabilities |
6
N/A
|
3
-57%
|
17
+538%
|
19
+13%
|
14
-23%
|
42
+190%
|
72
+73%
|
72
0%
|
222
+207%
|
397
+79%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
8
|
20
|
48
|
77
|
108
|
176
|
279
|
409
|
596
|
836
|
|
| Additional Paid In Capital |
5
|
67
|
69
|
93
|
109
|
355
|
393
|
425
|
706
|
1 027
|
|
| Total Equity |
3
N/A
|
46
N/A
|
22
-53%
|
17
-23%
|
1
-95%
|
179
+19 756%
|
114
-36%
|
16
-86%
|
110
+603%
|
191
+74%
|
|
| Total Liabilities & Equity |
3
N/A
|
49
+1 654%
|
38
-22%
|
36
-7%
|
15
-57%
|
221
+1 332%
|
186
-16%
|
88
-53%
|
332
+278%
|
588
+77%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
11
|
19
|
19
|
26
|
30
|
37
|
37
|
38
|
44
|
47
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
